United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$386Mraised across 6 rounds since 2012, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
TPG
Omega FundsReported by FinSMEsSEC filing: $41M sold, first sale Jul 2017
No investor was named in the report.
Reported by sec.govSEC filing: $6.6M sold, first sale Dec 2012
From the SEC filings it signed: 4 on the team.
On the board, as filediAnne L. VanLentDavid L. MeekerDominick L. ColangeloEdward L. MathersJames L. CassellaMichael L. Heffernan
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Omega Funds
New Enterprise AssociatesTPG
Vivo CapitalAdage Capital Management
Square 1 BankAperture
Solar CapitalNew Enterprise Associates/ LundbeckfondenMissing a round, or an investor who was in one? Tell us.
Trevi Therapeutics's investors include Omega Funds, New Enterprise Associates, TPG, Vivo Capital and Adage Capital Management, and 4 more on record.
Trevi Therapeutics has raised $386M across 6 rounds since 2012.
Trevi Therapeutics's most recent round was an Undisclosed round of $173M in Apr 2026.
Its most recent round, $173M in Apr 2026, is also its largest on record.
Trevi Therapeutics's first round on record, in Nov 2014, was backed by TPG.
Trevi Therapeutics's latest named round is an Undisclosed round, in Apr 2026.
Trevi Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
